Surgery for recurrent prostate cancer to remove affected lymph nodes
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a surgery to remove lymph nodes in the pelvis that still show cancer after your initial prostate cancer treatment. By taking them out, it may help control the cancer and delay the need for stronger treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult male.
- You had treatment for prostate cancer before, but the cancer reappeared in a few lymph nodes.
- You have 4 or fewer affected lymph nodes, and they are in no more than 3 areas (basins) in your body.
- The affected nodes are seen on a special PET scan (called PSMA-PET/CT).
- Your care team believes surgery to remove those nodes is a good option for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether operating on a small, one-sided (unilateral) area of prostate cancer spread in the pelvic lymph nodes—found on a PSMA PET scan—can help control recurrence. It’s meant for people whose PSA is still low and whose spread appears limited on the scan.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This study tests whether a special prostate scan called PSMA PET/CT can help doctors decide which pelvic lymph nodes to remove during prostate surgery. It may improve who needs lymph node surgery by using scan results to guide the operation.
This trial compares two surgical approaches for removing lymph nodes during prostate cancer surgery in men with high-risk disease on one side of the prostate. The goal is to determine whether removing lymph nodes from both sides or just one side provides better outcomes.
This trial tests a precise type of radiation therapy (called SABR) for prostate cancer that has returned in the lymph nodes only. It aims to control the cancer with fewer side effects and might offer a treatment option when surgery or other standard treatments are no longer enough.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.